Griffin Stephen D. 4
4 · Anika Therapeutics, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Anika (ANIK) CEO Stephen Griffin Receives 19,236 Shares; Tax Withheld
What Happened
Stephen D. Griffin, President & CEO and a director of Anika Therapeutics (ANIK), had equity awards vest on March 14, 2026. A total of 19,236 shares were issued on vesting (12,824 from RSUs and 6,412 from performance-based PSUs). To satisfy tax-withholding obligations, 5,944 shares were retained by the issuer at an effective withholding price of $14.20 per share (total value withheld ≈ $84,405). The remaining net shares issued to Griffin were 13,292. The Form 4 reports the RSU/PSU vesting and the share withholding (codes A = award, M = conversion/exercise of derivative, F = tax withholding).
Key Details
- Transaction date: March 14, 2026 (reported on Form 4 filed March 17, 2026).
- Shares issued on vesting: 12,824 (RSU installment) and 6,412 (PSU first vesting installment).
- Shares withheld for taxes: 5,944 @ $14.20 = $84,405 (reported as disposition for tax withholding).
- Net shares added to Griffin’s holdings from this vesting: 13,292 (19,236 issued − 5,944 withheld).
- Shares owned after the transaction: not specified in the provided excerpt; see the full Form 4 for total holdings.
- Notable footnotes: RSUs = contingent right to one share; PSUs and RSUs were granted on March 14, 2025 and vest in three equal annual installments starting March 14, 2026. The withholding was to satisfy tax liabilities on vested awards.
- Timeliness: Filing date is March 17, 2026 for a March 14, 2026 transaction; no late-filing flag indicated.
Context
This was a routine equity vesting event for previously granted RSUs and PSUs rather than an open-market buy or sale. The tax-withholding (share retention by the company) is common practice and reflects payment of tax obligations on the vested awards, not a discretionary sale by the insider. For investors, vesting confirms compensation dilution and insider exposure but does not necessarily signal buy/sell intent.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-14+12,824→ 23,495 total - Award
Common Stock
[F2]2026-03-14+6,412→ 29,907 total - Tax Payment
Common Stock
[F3]2026-03-14$14.20/sh−5,944$84,405→ 23,963 total - Exercise/Conversion
Restricted Stock Unit
[F1][F4]2026-03-14−12,824→ 25,649 total→ Common Stock (12,824 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- [F2]On March 14, 2025, the Reporting Person was granted 19,236 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
- [F3]Reflects an aggregate of 5,944 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
- [F4]On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.